<< Back to News

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Webinar on Novel Quantitative Immunohistochemistry Technology and Associated Applications

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Original Webinar Date Was:
Wednesday, August 22, 2018

10:30AM EST

Presenter: Kenneth J. Bloom, M.D., FCAP
Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

This webinar was led by Dr. Kenneth Bloom, Chief Medical Officer of Advanced Genomic and Pathology Services for Konica Minolta’s Precision Medicine Businesses. Dr. Bloom described Konica Minolta’s quantitative and ultra-sensitive phosphor integrated dot (PID) nanoparticle technology. He also presented several associated applications and case studies.

Miss the webinar and want to view the recording? Fill out the form below to proceed.


Kenneth J. BloomAbout Kenneth J. Bloom:

Dr. Bloom has more than 30 years of clinical experience and has been an early adopter of precision medicine. He is a renowned researcher and lecturer in pathology, cancer, telemedicine, and informatics.

Dr. Bloom recently joined Invicro as the CMO of advanced pathology and advanced genomic services. Prior to Invicro, he served as the President and head of oncology and immunotherapy at Human Longevity Inc., Chief Medical Officer of In Vitro Diagnostics at GE Healthcare, senior medical director at US Labs and director of laboratory operations at Rush Medical Center. Dr. Bloom has held a series of academic position as including Clinical Professor of Pathology at USC and CIO at Rush Cancer Center.

<< Back to News